WELVISTA
AI Summary
WELVISTA is a nonprofit organization dedicated to providing access to donated prescription medication for the uninsured and oral health care for low-income children, with a focus on public health. In the 2025 filing year, the organization operates with a budget of $97.5 million and reported total revenue of $96 million, supported by a diverse range of funders. For more information, visit their website at www.welvista.org.
Mission Statement
PROVIDE ACCESS TO DONATED PRESCRIPTION MEDICATION TO THE UNINSURED AND ORAL HEALTH CARE TO LOW-INCOME CHILDREN.
Cause Areas
1
Public health
Explore this org's ecosystem
See similar nonprofits by cause and location, their funders, and their grants.
Explore this org's ecosystem
See similar nonprofits by cause and location, their funders, and their grants.
Charity Verification Snapshot
IRS EO Business Master File Status
Listed as tax-exempt
IRS Pub 78 Status
Eligible for tax-deductible gifts
IRS Revocation Status
Not in Automatic Revocation of Exemption List
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Frequently Asked Questions
What is WELVISTA’s budget?
In 2025, WELVISTA reported an annual operating budget of around $97.5 million. More detailed financial information is available to registered users.
What causes does WELVISTA support?
WELVISTA supports work in Public health.
Where does WELVISTA operate?
WELVISTA is headquartered in Columbia, SC.
Who funded WELVISTA recently?
In 2024, WELVISTA received grants from THE DUKE ENDOWMENT, THE LEON LEVINE FOUNDATION, and PFIZER PATIENT ASSISTANCE FOUNDATION INC. More information on this organization’s funders is available to registered users.
What is the largest grant WELVISTA received in 2024?
The largest grant to WELVISTA in 2024 exceeds $475 thousand.
What is WELVISTA’s reliance on government grants?
WELVISTA relied on government grants for more than 5% of their total revenue in 2025.